Expression of DPC4/Smad4 in non-small-cell lung carcinoma and its relationship with angiogenesis

Neoplasma

Volumn 55, Issue 4, 2008, Pages 323-329

  Ke, Z ^a,b   Zhang, X ^c   Ma, L ^a,b   Wang, L ^a,b  

^a SUN YAT SEN UNIVERSITY   (China)

^b SUN YAT SEN UNIVERSITY   (China)

^c GUANGZHOU MEDICAL UNIVERSITY   (China)

Author keywords

Angiogenesis; DPC4; Lung cancer; TSP 1; VEGF

Indexed keywords

CD34 ANTIGEN; MESSENGER RNA; SMAD4 PROTEIN; SMALL INTERFERING RNA; THROMBOSPONDIN 1; VASCULOTROPIN; 4 AMINO 6,7 DIMETHOXY 2 [4 [5 (4 AMINOPHENYL)VALERYL] 1 PIPERAZINYL]QUINAZOLINE; DRUG DERIVATIVE; PRAZOSIN; SMAD4 PROTEIN, HUMAN; VASCULOTROPIN A;

ADULT; AGED; ANGIOGENESIS; ARTICLE; BRONCHUS MUCOSA; CANCER CELL CULTURE; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; LUNG NON SMALL CELL CANCER; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; PROTEIN EXPRESSION; TRACHEA MUCOSA; WESTERN BLOTTING; FEMALE; GENETIC TRANSFECTION; IMMUNOHISTOCHEMISTRY; LUNG TUMOR; MALE; METABOLISM; MIDDLE AGED; NEOVASCULARIZATION (PATHOLOGY); TUMOR CELL LINE;

ADULT; AGED; CARCINOMA, NON-SMALL-CELL LUNG; CELL LINE, TUMOR; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; PRAZOSIN; SMAD4 PROTEIN; THROMBOSPONDIN 1; TRANSFECTION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 49949119455     PISSN: 00282685     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. HAHN SA, SCHUTTE M, HOQUE AT et al. DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1. Science 1996; 271: 350-353. (Pubitemid 3021510)
2. XIN Q, GUAN Y, LEILEI Y et al. Essential role of Smad4 in maintaining cardiomyocyte proliferation during murine embryonic heart development. Dev Biol 2007; 311: 136-146.
3. Nicolussilletta G, Coppa A. TGF-β control of rat thyroid follicular cells differentiation. Mol. Cell. Endocrinol 2003; 207: 1-11
4. KANG YK, KIM WH, JANG JJ. Expression of G1-S modulators (p53, p16, p27, cyclin D1, Rb) and Smad4/Dpc4 in intrahepatic cholangiocarcinoma. Hum Pathol 2002; 33: 877-883.
5. SANTIBANEZ JF, QUINTANILLA M, MARTINEZ J. TGF- β1 and Smad4 overexpression induce a less invasive phenotype in highly invasive spindle carcinoma cells. FEBS Lett 2002; 20: 171-176.
6. NAGATAKE M, TAKAGI Y, OSADA H et al. Somatic in vivo alterations of the DPC4 gene at 18q21 in human lung cancers. Cancer Res 1996; 56: 2718-2720 (Pubitemid 26175725)
7. SCHUTTE M, HRUBAN RH, HEDRICK L et al. DPC4 gene in various tumor types. Cancer Res 1996; 56: 2527-2530.
8. DEVEREUX TR, ANNA CH, PATEL AC et al. Smad4 (homolog of human DPC4) and Smad2 (homolog of human JV18-1): candidates for murine lung tumor resistance and suppressor genes. Carcinogenesis 1997; 18: 1751-1755.
9. GREENBLATT M, SHUBI P. Tumor angiogenesis: transfilter diffusion studies in the hamster by the transparent chamber technique. J Natl Cancer Inst 1968; 41: 111-124.
10. EHRMANN RL, KNOTH M. Choriocarcinoma. Transfilter stimulation of vasoproliferation in the hamster cheek pouch. Studied by light and electron microscopy. J Natl Cancer Inst 1968; 41: 1329-1341.
11. KHORANA AA, HU YC, RYAN CK et al. Vascular endothelial growth factor and DPC4 predict adjuvant therapy outcomes in resected pancreatic cancer. J Gastrointest Surg 2005; 9: 903-911.
12. SCHWARTE-WALDHOFF I, VOLPERT OV, BOUCK NP et al. Smad4/DPC4-mediated tumor suppression through suppression of angiogenesis. Proc Natl Acad Sci U S A 2000; 97: 9624-9629. (Pubitemid 30650826)
13. THIAGALINGAM S, LENGAUER C, LEACH FS et al. Evaluation of candidate tumour suppressor genes on chromosome 18 in colorectal cancers. Nat Genet 1996; 13: 343-346. (Pubitemid 26230501)
14. SHEEHAN GM, KALLAKURY BV, SHEEHAN CE et al. Smad4 protein expression correlates with grade, stage, and DNA ploidy in prostatic adenocarcinomas. Hum Pathol 2005; 36: 1204-1209
15. SHEEHAN A, MOLBERG K, ALBORES-SAAVEDRA, J et al. Loss of Dpc4 expression in colonic adenocarcinomas correlates with the presence of metastatic disease. Am J Pathol 2000; 157: 1105-1111.
16. MIYAKI M, IIJIMA T, KONISHI M et al. Higher frequency of Smad4 gene mutation in human colorectal cancer with distant metastasis. Oncogene 1999; 18: 3098-3103.
17. AMIR O, ROY SH. Angiogenesis and lung cancer: implications for prognosis and treatment. The Lancet Oncology 2007; 8: 460-461. (Pubitemid 46805909)
18. KERBEL RS. Tumor angiogenesis: past, present and the near future. Carcinogenesis 2002; 21: 505-515.
19. LEVY AP, LEVY NS, GOLDBERG MA. Post-transcriptional regulation of vascular endothelial growth factor by hypoxia. J Biol Chem 1996; 271: 2746-2753. (Pubitemid 26047892)
20. BROWN LF, DETMAR M, CLAFFEY K et al. Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am J Pathol 1995; 146: 1029-1039.
21. TUSZYNSKI GP, GASIC TB, ROTHMAN VL et al. Thrombospondin, a potentiator of tumor cell metastasis. Cancer Res 1987; 47: 4130-4133. (Pubitemid 17108482)
22. ROTH JJ, REIVER DM, GRANICK MS et al. Histopathology and clinical assessment correlate with the cysteine- serinevaline- threonine-cysteine-glycine (CSVTCG) receptor of thrombospondin-1 in breast tumors. Histopathol 1997; 12: 1013-1018
23. ALBO D, BERGER DH, TUSZYNSKI GP. The effect of thrombospondin- 1 and TGF-beta 1 on pancreatic cancer cell invasion. J Surg Res 1998; 76: 86-90. (Pubitemid 28363860)
24. ZABRENETZKY V, HARRIS CC, STEEG PS et al. Expression of the extracellular matrix molecule thrombospondin inversely correlates with malignant progression in melanoma, lung and breast carcinoma cell lines. Int J Cancer 1994; 59: 191-195.